• Applied Cancer Research with EZ Cap™ Human PTEN mRNA (ψUTP)

  2026-04-24

  EZ Cap™ Human PTEN mRNA (ψUTP) empowers researchers to restore tumor suppressor signaling and overcome resistance in advanced cancer models. This workflow-driven guide translates cutting-edge mRNA delivery strategies into actionable protocols, troubleshooting tips, and comparative insights for robust, reproducible gene expression studies.

• GSK621 (SKU B6020): Optimizing AMPK Agonist Applications in

  2026-04-24

  This article addresses real-world challenges in cell viability and metabolic pathway assays, demonstrating how GSK621 (SKU B6020) delivers robust, reproducible results for acute myeloid leukemia and immunometabolic research. Scenario-driven Q&A blocks clarify best practices, protocol optimization, and vendor selection, with evidence-based guidance tailored for biomedical researchers.

• 25-Hydroxycholesterol-AMPK Axis Shapes Immunosuppressive Mac

  2026-04-23

  Xiao et al. (2024) uncover how 25-hydroxycholesterol accumulation in tumor-associated macrophages activates lysosomal AMPKα via a GPR155–mTORC1 pathway, driving STAT6 phosphorylation and immunosuppressive reprogramming. Targeting this metabolic axis modulates macrophage phenotype and enhances anti-tumor immunity, offering a mechanistic rationale for metabolic intervention strategies.

• Polystyrene Nanoparticles Enhance IR-1061 NIR Imaging for De

  2026-04-23

  The referenced study introduces a method for formulating highly emissive near-infrared (NIR, >1000 nm) fluorescent dye-loaded polystyrene nanoparticles, optimizing their polarity and surface chemistry for robust in vivo deep tissue imaging. By tuning nanoparticle composition and the loading environment, the authors address key limitations of existing organic dyes for biomedical imaging.

• Z-VEID-FMK: Precision Caspase-6 Inhibitor for Apoptosis Assa

  2026-04-22

  Z-VEID-FMK delivers unmatched specificity in dissecting caspase-6-dependent apoptosis, enabling confident analysis in neuronal, immune, and viral infection models. Its robust performance in both standard and advanced workflows makes it the caspase-6 inhibitor of choice for researchers seeking reliable, actionable results.

• Staurosporine: Broad-Spectrum Serine/Threonine Kinase Inhibi

  2026-04-22

  Staurosporine is a potent, broad-spectrum serine/threonine protein kinase inhibitor used extensively in cancer research and apoptosis assays. Its high affinity for PKC isoforms and VEGF receptor kinases underlies its role as a benchmark apoptosis inducer and anti-angiogenic agent. Sourced from APExBIO, Staurosporine enables reproducible, high-sensitivity kinase pathway interrogation.

• Lactate–GPR81–FARP1 Axis Enables Insulin-Independent Glucose

  2026-04-21

  This study uncovers a lactate-triggered signaling pathway (GPR81–FARP1–RAC1) that promotes glucose uptake independently of insulin, with significant implications for hyperglycemia management. By detailing the molecular mechanisms and physiological relevance, the research offers new avenues for metabolic disease intervention beyond classical insulin signaling.

• FAPα-Sensitive Nanoparticle Probes for Noninvasive Tumor Dia

  2026-04-21

  This study introduces a synthetic urinary probe–coated magnetic nanoparticle system that selectively responds to fibroblast activation protein α (FAPα) activity within solid tumors, enabling noninvasive cancer diagnosis via urinary peptide detection. The approach demonstrates high specificity and diagnostic accuracy for FAPα-positive tumor identification, providing a promising platform for early cancer detection and potential clinical translation.

• Ciprofloxacin Workflows: Advancing Antimicrobial Resistance

  2026-04-20

  Ciprofloxacin, a benchmark fluoroquinolone antibiotic, enables high-fidelity modeling of antimicrobial resistance and DNA replication inhibition at the bench. This guide delivers workflow enhancements, troubleshooting insights, and data-driven protocol parameters leveraging APExBIO’s high-purity Ciprofloxacin for cutting-edge resistance research.

• 3-(1-methylpyrrolidin-2-yl)pyridine (N2703): Precision Tools

  2026-04-20

  Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) empowers advanced research into cellular signaling pathway modulation. This article offers a unique, in-depth analysis of N2703's mechanistic applications and practical assay guidance, setting it apart from standard overviews.

• Sildenafil Citrate: Applied Workflows for PDE5 Inhibition Re

  2026-04-19

  Sildenafil Citrate from APExBIO empowers advanced studies in cGMP signaling, vascular relaxation, and proteoform-specific drug targeting. This guide translates recent proteomics breakthroughs into actionable protocols, troubleshooting advice, and comparative insights for researchers investigating vascular function and signal transduction.

• Captopril as an ACE Inhibitor: Protocols and Advanced Resear

  2026-04-18

  Captopril stands out as a gold-standard ACE inhibitor, supporting not only hypertension research but also pioneering studies in oncology and bradykinin pathway modulation. This guide details practical workflows, troubleshooting insights, and novel applications, enabling scientists to maximize the compound's potential across cardiovascular and cancer research.

• Deciphering Aneugenic Mechanisms: Molecular Profiling with 2

  2026-04-17

  This study introduces a two-tiered molecular mechanism assay to distinguish between tubulin interactors and mitotic kinase inhibitors among 27 reference aneugens. By integrating multiplex biomarker flow cytometry and machine learning, the research establishes a robust framework for elucidating aneugenic mechanisms relevant to cancer biology and preclinical safety assessment.

• GLT-1 Upregulation Counters CB1-CREB Pathway Dysfunction in

  2026-04-16

  This study demonstrates that enhancing GLT-1 expression in astrocytes mitigates neuronal apoptosis and cognitive deficits after traumatic brain injury (TBI) by suppressing the CB1-CREB signaling pathway. These findings clarify the mechanistic link between endocannabinoid signaling, glutamate transport, and neuroprotection, offering new strategies for memory impairment research.

• Epalrestat: Aldose Reductase Inhibitor for Neuroprotection R

  2026-04-15

  Epalrestat, a high-purity aldose reductase inhibitor from APExBIO, excels in both diabetic complication and neurodegeneration models by targeting polyol pathway and KEAP1/Nrf2 signaling. This article details optimized workflows, real-world troubleshooting, and actionable tips to maximize reproducibility in oxidative stress and Parkinson’s disease research.

15451 records 1/1031 page Next 12345 下5页 Last page